Mr. Hoshang N. Sinor
Mr. Hoshang is an independent director on the board since 2003 and a member of the Company’s Audit Committees and the Remuneration Committee.
A veteran banker with a banking career spanning over four decades and retired as Jt. Managing Director of ICICI Bank in 2003. He thereafter ran the bankers trade body, Indian Bank’s Association, for over 5 years. He is currently the Chief Executive of Association of Mutual Funds in India.
Dr. Dinesh Shantilal Patel
Executive Vice Chairman (w.e.f 14th February, 2017)
Dr. Dinesh is the Executive Vice Chairman on the board and former Managing Director & CEO. He holds a doctorate in Medicinal Chemistry. He is a Fellow of the Royal Society of Chemistry, London, U.K. He joined the business in 1973. His area of expertise are research, biotechnology, banking and general business administration.
Dr. Sachin Dinesh Patel
Managing Director & CEO (w.e.f 14th February, 2017)
Dr. Sachin was formerly a Deputy Managing Director and a Director – Business Development on the board since 2004 and has been re-designated as Managing Director & CEO since 14th February, 2017 on the board and he is son of the Executive Vice Chairman of the Board. He holds a doctorate in Biological Chemistry from Christ’s college, University of Cambridge, UK.
Dr Gábor Gulácsi
Appointed as Deputy Managing Director upon joining Gedeon Richter in 2000. Responsible for Finance. Economist, University doctorate in Economic Sciences. Previously General Secretary of State, Ministry of Economic Affairs in Hungary.
Mr. Lajos Kovacs
Mr. Lajos was appointed Director in 2005. Responsible for technical services. Chemical engineer with postgraduate degree in pharmaceutical research. With Richter since 1984 in a number of roles. Research fellow at the University of Liverpool (UK) between 1987 and 1989.
Mr. Rajneesh Anand
Mr. Anand is a graduate in Mechanical Engineering from M.S. University, Baroda, and is a postgraduate in Management from Jamnalal Bajaj Institute, Bombay University. He is a certified Chartered Engineer.
He is the CEO & Director of Richter Themis Medicare (I) Pvt. Limited the second joint venture compant between Gedeon Richter Ltd. and Themis Medicare in India. He has been associated with Themis Chemicals since 1977. Presently he holds the position of President and CEO in Gujarat Themis Biosyn Limited having a joint venture with with Yuhan Corporation of Korea.
Mr. Vijay Agarwal
Mr. Vijay is an indepent director on the board since 2002. He is also a member of the Company’s Audit Committee & Remuneration Committee. He is a practising Chartered Account with expertise in finance and taxation.
Mr. Hariharan Subramaniam
An Indian Patent Attorney with over 32 years experience and have been involved in all aspects of IP law including filing, prosecution and enforcement. Have filed patent applications in every country in the world. He was voted No. 1 Patent Attorney by several leading law magazines and was featured in the cover story ‘Top 50 IP lawyers you must know in Asia and Pacific’ in the March Issue of Asia Law magazine. Vice president of Anti Counterfeiting Group of India.
Mr. Humayun Dhanrajgir
Mr. Humayun is an Indepedent Director of the board since 2004, in addition to being Chairman of the Company’s Audit Committee and a member of Remuneration Committee.
A respected personality in the Pharmaceutical Industry with over 40 years. He has held several senior positions including that of the Managing Director and Vice Chairman of Glaxo India Ltd. in the early 90’s. He was the president of OPPI- Organization of Pharmaceutical Producers of India (’90-’92). He also served on the General Committee of the Bombay Chamber of Commerce and Industry and was the Chairman of its Indo-British Business Committee for 2 years. He was also the MD of Lupin Laboratories for 1 year from October 1994 to assist in the company’s globalization plans. He was thereafter appointed by Eastman Kodak Company and Managing Director of Kodak India Ltd. for a 5 year term and retired in October 2000.
Her serves on the Boards of a few public companies notably HDFC Asset Management Company, Cadila Healthcare and Zydus Wellness. He is the non executive chairman of Emcure Pharmaceuticals Ltd. and Next Gen Publishing Ltd. He is a Trustee of the Breach Candy Hospital Trust and an Advisory Board Member of US Pharmacopeaia, India.
We want to take the world from pain to pain-free parentals through pain free work on dedicated innovations. Emal – the first in the world injectable against critical malaria, Etojet – the worlds first painless Etrocoxib injection and a first of its kinds injectable.
Diclofenac sodium for pain relief, are all a result of pursuit of ideas taken to their full potential. Our aim is to make disease management easier and painless for both patients and healthcare professionals.
- Intimation under regulation 39(3) 9f Securities and Exchange Board of India (Listing Obligations and Disclosure Reguirements) Regulation, 2015 I“SEBI (LODR) Regulations, 2015″] 02/Apr/2019
- Change in directors of company 27/Mar/2019
- lntimation under regulation 39(3) of Securities and Exchanae Board of India (Listinq Obligations and Disclosure Requirements) Requlation, 2015 [“SEBI (LODR) Regulations, 2015″] 07/Mar/2019
- Intimation of Resolution by circulation passed by Board of Directors. 02/Mar/2019
- Outcome of Board Meeting – 08 Feb 2019 08/Feb/2019
11/12, Udyog Nagar,
S. V. Road, Goregaon (W),